Human cytomegalovirus (HCMV) replication requires remodeling of the host metabolic network, 36
AMPK through Ca 2+ -calmodulin-dependent kinase kinase (CaMKK) activity (32) . CaMKK is 96 required for HCMV hijacking of glycolysis (22) . HCMV limits AMPK downregulation of FA 97 synthesis (33). HCMV induced ELOVL7 activity requires the early viral protein pUL38 (12) . 98 pUL38 prevents mammalian target of rapamycin (mTOR) inactivation and induces the 99 maturation of sterol regulatory element binding proteins (SREBPs) transcription factors to 100 enhance FA metabolism (12, 33, 34) . In addition to mTOR, other kinases are also used by 101
HCMV to hijack metabolism. The endoplasmic reticulum (ER) stress kinase, PKR-like ER kinase 102 (PERK, also known as eukaryotic translation initiation factor 2-alpha kinase 3, EIF2AK3) is also 103 activated by HCMV to increase lipid synthesis (29) . 104
105
Although some of the host factors that HCMV uses to modulate specific metabolic pathways 106 have been defined, little is known about the viral factors that required to coordinate the hijacking 107 of the host metabolic network beyond our initial understanding of the role of pUL38. Since 108 CaMKK activity is stimulated by Ca 2+ , viral stimulation of glycolysis may depend on intracellular 109 Ca 2+ mobilization. HCMV infection increases intracellular Ca 2+ concentrations (35) . HCMV 110 pUL37x1 protein triggers the release of ER stored Ca 2+ into the cytosol (36). Thus, pUL37x1 111 mediated increase of Ca 2+ into the cytosol could alter metabolism (Fig. 1 ). In addition to Ca 2+ 112 release, pUL37x1 blocks apoptosis and targets the mitochondria (37-40) while increasing the 113 fragmentation of the mitochondrial network (41). Given the importance of the mitochondria to 114 metabolism, this could be an additional mechanism for HCMV metabolic control (Fig. 1) . 115 pUL37x1 traffics to the outer mitochondrial membrane where it contacts the ER (42). The 116 subcellular location of pUL37x1 or stress-associated with the release of stored ER Ca 2+ may 117 influence ER-related metabolism, such as FA elongation and lipid synthesis. 118 119 Given pUL37x1 function in Ca 2+ mobilization and localization to membranes important for 120 metabolism, we-and others (18, 22, 43, 44) -hypothesize that HCMV metabolic remodeling 121 requires pUL37x1. We tested this hypothesis using a mutant virus that lacks the UL37x1 gene 122 (36, 45) in combination with metabolomics, lipidomics and metabolic tracing experiments. We 123 found that pUL37x1 is required for the overall robustness of HCMV metabolic remodeling; 124 however, the virus is able to induce metabolic hijacking independent of pUL37x1. Specifically, 125 pUL37x1 supports HCMV induction of FA and lipid metabolism while increasing ELOVL7 and 126 PERK protein levels. Moreover, our findings establish that HCMV infection results in a robust 127 increase in phospholipids with very long chain fatty acid (PL-VLCFA) tails. pUL37x1 is important 128 for the dramatic increase in these PL-VCFAs. Additionally, pUL37x1 suppresses the levels of 129 phosphatidylserine lipids with shorter tails that are associated with apoptotic signaling. The 130 findings reported here improve our understanding of the viral mechanisms used by HCMV to 131
Results: 138 139
Active HCMV replication requires the products of various metabolic pathways including those 140 involved in energy, amino acid, nucleotides, fatty acids and lipids. HCMV pUL38 prevents 141 mTOR deactivation and stimulates SREBP maturation and fatty acid elongation (12, 33) . 142
Beyond pUL38, we have a limited understanding of the viral mechanisms used to alter varied 143 metabolic pathways. We and others (43) hypothesize that pUL37x1 is required for HCMV 144 metabolic control. We directly tested this hypothesis by comparing the viral control of metabolite 145 concentrations in WT infected cells to those infected with a mutant virus that lacks the UL37x1 146 gene (36). 147
148

Global metabolome remodeling by HCMV occurs largely independent of pUL37x1 149
Our work builds on the well-defined HCMV remodeling of the metabolome of primary human 150 fibroblast cells under fully-confluent, serum-free conditions (11, 12, 14-17, 22, 23, 32, 33) . Since 151 most prior characterization of pUL37x1-null viruses was done under sub-or near-full confluent 152 conditions in the presence of animal serum, we briefly characterized the mutant virus infection in 153 confluent, serum-free conditions. We confirmed that our pUL37x1-null mutant virus, subUL37x1 154 (36), expresses pUL36 and pUL38 while ablating pUL37x1 expression ( Fig. 2A ). The cytopathic 155 effect (CPE) characterized by WT infection-e.g. visual cytomegaly-was lessened in cells 156 infected with the subUL37x1 mutant ( Fig. 2B ). At the later stages of infection, a greater amount 157 of cellular debris was observed in mutant virus infected cells, consistent with an increase in cell 158 death at 3-4 days post infection (dpi) (Fig. 2B ). We observed a strong loss in virus replication 159 with UL37x1 deletion (Fig. 2C ). Furthermore, the loss of pUL37x1 also resulted in the release of 160 fewer infectious virions per total released viral particles ( Fig. 2D ). Overall, these results were 161 consistent with observations of UL37x-1 null mutant viruses in sub-confluent cells grown in 162 serum (36, 38, 39) . 163
Next, we tested if pUL37x1 is required for viral hijacking of the host metabolome using liquid-165 chromatography high-resolution tandem mass spectrometry (LC-MS/MS). Infection with WT 166 AD169 virus resulted in a global remodeling of metabolites that were most dramatically changed 167 at 1 dpi and later ( Figure 3A ). HCMV strongly increases glycolytic and TCA cycle metabolites 168 along with others that have been previously described (11, 14, 15, 19, 21, 22, 46) . Infection with 169 the mutant subUL37x1 virus similarly altered metabolite levels starting at 1 dpi ( Figure 3A ). The 170 correlation between metabolic profiles of WT and subUL37x1 infected cells was low early in 171 infection ( Fig. 3B , 6 hpi) but strongly correlated at later time points ( Fig. 3B , 1-3 dpi). 172
Importantly, glycolytic and TCA metabolites-e.g., hexose-phosphate, pyruvate, malate, α-173 ketoglutarate, and succinate-were increased in subUL37x1-infected cells compared to 174 uninfected cells but were slightly reduced compared to WT-infected cells (Fig. 3A) These 175 findings demonstrated that pUL37x1 may contribute to HCVM remodeling of specific metabolic 176 pathways, but is not required for the global hijacking of the host metabolism. Our metabolomic studies examined water-soluble metabolites. Hydrophobic compounds 180 including lipids and fatty acids were not included in this type of analysis. HCMV enhances FA 181 synthesis and dramatically increases FA elongation (11, 12, 17) . FA synthase (FAS) forms long-182 chain FAs up to 16 carbons in length (C16) by connecting carbons, two at time. The product of 183 FAS is 16-carbon saturated FA palmitate (C16:0, the number following the colon represents the 184 number of double bonds in the FA). Palmitate can be processed further to make longer chains 185 and/or desaturated to introduce a double bond among the carbons in the tail. In humans, longer 186
FAs are made by one or more of the seven FA elongases (ELOVL1-7), again adding one 2-187 carbon unit per reaction cycle. We have previously shown that HCMV significantly increases the concentration of saturated very-long chain FAs (VLCFA), specifically those with 24 or more 189 carbons (>C24) (12, 17). 190 191 To determine if pUL37x1 is important for HCMV induced FA metabolism, we measured FAs 192 extracted from lipids of infected and mock-infected control cells. In cells infected with WT virus, 193 saturated VLCFAs were increased by as much as 9-fold compared to uninfected cells 194 confirming our previous observations ( Fig. 4) (12, 17) . While subUL37x1 virus increased some 195
FAs compared to uninfected cells, the mutant virus failed to induce WT-like levels of VLCFAs at 196 2 and 3 dpi ( Fig 4) . 197
198
FA elongation can be monitored by measuring the incorporation of 13 C from labeled glucose into 199
FAs using LC-MS, i.e., non-tandem MS1-only analysis (12, 17, 47) . Following a 1h infection 200 period, we fed WT and subUL37x1 infected cells medium that contained 13 C-labeled glucose at 201 positions 1 and 6 (1,6-13 C-glucose). Glycolytic breakdown of this labeled form of glucose will 202 result in 1-labeled pyruvate ( Fig. 5A ). Pyruvate can be further metabolized generating 1-labeled 203 citrate in the mitochondria. Citrate can be exported into the cytoplasm where it is broken down 204 into 1-labeled acetyl-CoA and unlabeled oxaloacetate. Alternatively, pyruvate may breakdown 205 into acetate that can be converted to acetyl-CoA (24, 48) . The conversation of acetyl-CoA to 206 malonyl-CoA by acetyl-CoA carboxylase 1 (ACC-1) is the rate-limiting step of fatty acid 207 synthesis and elongation. In our labeled cells this will result in 1-labeled malonyl-CoA per 2-208 carbon unit used for FA synthesis and elongation. 209
210
Using LC-MS to measure the overall percent of FA tails that have one or more 13 C atoms, we 211 observed that uninfected cells have minimal to no labeling of FAs after correcting for the natural 212 isotopic abundance of 13 C. This is consistent with the cells being in a non-growing state due to 213 contact-inhibition and serum-starvation. HCMV infection, however, strongly induced FA anabolism. In WT-infected cells a significantly higher proportion of FAs were labeled, and the 215 greatest labeling occurred in longer FAs (Fig. 5B ). SubUL37x1 also induced FA metabolism 216 compared to uninfected cells ( Fig. 5B ), however the labeling rate was less than that observed in 217
WT-infected cells. For example, more than half of the C26:0 was labeled during WT-infection 218 while only a quarter was labeled in subUL37x1-infected cells. In addition to a reduction in the 219 percent of labeling, the FAs isolated from mutant virus infected cells had fewer number of 13 C 220 atoms ( Fig. 5D ). In WT infected cells, we were able to observe up to 4-5 labeled atoms (or the 221 incorporation of 8-10 new carbons). This observation was similar to that observed in cells fed 222
uniformly labeled 13 C-glucose where two 13 C atoms are added per 2-carbon units (12, 17) . 223
However, subUL37x-1 infection resulted in only 1-2 labeled atoms indicating that only one to 224 two 2-carbon units were added. 225
226
Our glucose labeling strategy measured the carbon contribution of both citrate and acetate that 227 is derived from glucose. Since HCMV infection increases the contribution of acetate feeding into 228 lipid synthesis (24), we measured the contribution of acetate to HCMV-induced FA elongation 229 using 13 C-labeled acetate. In this case both atoms of the 2-carbon unit were labeled. Again, 230 cells were fed labeled acetate following a 1h infection period. Similar to the labeled-glucose 231 tracer, only minimal labeling from acetate was observed in uninfected cells ( Fig. 5C ). Infection 232 increased acetate derived atoms incorporated into VLCFAs (Fig. 5C ). In WT-infected cells 30% 233 of C26:0 was labeled from 13 C-acetate versus 60% labeling from glucose. Additionally, only 4 234 labeled atoms from two 2-carbon units were incorporated ( Fig 5E) . The subUL37x1 mutant virus 235 induced FA elongation from acetate, but to a lower level than WT ( Fig. 5C and 5E ). Together 236 our results reveal that pUL37x1 contributed to the ability of HCMV to induce FA elongation. 237
238
During infection, saturated VLCFAs are produced by ELOVL7 (12). HCMV increases the gene 239 and protein expression of ELOVL7 (12).We examined if HCMV-induced ELOVL7 expression 240 requires pUL37x1. In HFF cells, WT virus induced ELOVL7 expression by 2 dpi (Fig. 6 ), similar 241 to our observations in MRC-5 primary fibroblasts (12). Mutant subUL37x1 virus also induced 242 ELOVL7 expression, however at a reduced level compared to WT (Fig. 6 ). This observation is 243 consistent with a reduced ability of the mutant virus to induced FA elongation and the production 244 of saturated VLCFAs. 245
246
The pUL37x1 dependent FA synthesis of VLCFAs was consistent with a decreased ability of the 247 subUL37x1 mutant virus to induce ELOVL7 protein expression. However, pUL37x1 may also 248 affect other aspects of FA metabolism. In addition to ELOVL7, HCMV increases the protein 249 expression of ACC-1 and its phosphorylated form that reduces its activity (33). We found that 250 subUL37x1 also induced both forms of ACC-1 over mock levels ( Fig. 7 ). However, there was a 251 slight decrease in total ACC-1 levels compared to WT (Fig. 7) , consistent with a decrease in FA 252 elongation. Since the mutant virus has a strong defect in elongation from glucose derived 253 carbons we examined if pUL37x1 influences the expression of ATP citrate lyase (ACLY) that 254 converts citrate to acetyl-CoA in the cytosol. At late, time points in replication ACLY protein 255 levels are slightly higher in infected cells (28). We found that ACLY levels were similar in WT 256 and subUL37x1 infected cells at 2-4 dpi (Fig. 7) . Likewise, the ACSS2 enzyme that synthesizes 257 acetyl-CoA from acetate was unaffected by pUL37x1 ( Fig. 8) . 258 259 HCMV-induced metabolic remodeling requires AMPK. HCMV induces AMPK expression and 260 activity to increase glycolysis (21, 32). However, AMPK typically phosphorylates ACC-1 to 261 reduce its activity. We found that subUL37x1 induced the expression of the catalytic subunit of 262 AMPK, AMPKα, to WT-like levels suggesting that pUL37x1 is not acting through AMPK 263 mediated activity (Fig. 7) . In conclusion, pUL37x1 is required for HCMV induced FA metabolism, 264 and induction of ACC-1 and ELOVL7 protein expression. 265
Viral remodeling of host lipidome requires pUL37x1 267
One function of FAs is to act as hydrophobic tails in lipids. Given our observations in 268 we hypothesized that pUL37x1 is required for the synthesis of lipids with VLCFA tails. To test 269 this hypothesis, we developed LC-MS/MS lipidomic methods to examine phospholipids, 270
including those that contain C24 and C26 VLCFAs. We found that WT HCMV infection 271 dramatically increased phospholipids, especially those with VLCFA tails (PL-VLCFAs) ( Fig. 9A,  272 left panel). Phosphatidylcholines (PC) were particularly increased ( Fig. 9A-B) . A previous 273 lipidomic study demonstrated that PC lipid species with long chain fatty acid tails were 274 increased by HCMV, while those with shorter chains decreased (31). Notably, this previous 275 analysis only examined lipids with a total of 30-42 carbons in their tail. Since the identity of any 276 individual tail was not reported it is unlikely that this analysis included >C26 VLCFAs. Using our 277 LC-MS/MS methods, we examined lipids with up to 48 total carbons in their tails. HCMV 278 induced the levels of several PC species with 44-48 carbons in their tails ( Fig. 9B ). Of the top 279 six PC species increased by HCMV, their levels were increased 17-32-fold (PC(48:7)) to 270-280 14,00-fold (PC46:1)). In this case, the PC tails contain a total of 48 carbons and 7 double bonds 281 and 46 carbons and a single double bond, respectively. Since the number of carbons and 282 double bonds impart a large amount of diversity observed in lipidomes, we examined the tail 283 composition of these six PC species (Fig. 9D ). All contained a >C26 tail. The greatest diversity 284 was observed in PC(44:1). We found evidence of four different PC(44:1) species: C18:1+C26:0, 285 C18:0+C26:1, C16:0+28:1, and C14:0+C30:1. The C30 tail was the longest one observed. 286 287 When we examined phospholipids from subUL37x1 infected cells, we observed a significant 288 decrease in lipid levels compared to WT-infected cells (Fig. 9A, right panel) . The most notably 289 decreased lipids were the PC species that were greatly elevated by WT virus. All six of the PC 290 species discussed above were significantly decreased in mutant-virus infected cells compared 291 to WT (Fig. 9B ). However, all species with the exception of PC(48:5) were elevated above the 292 uninfected level by the mutant virus (Fig. 9B ). PC lipids are important for membranes, including 293 the virion envelope (31), suggesting that these lipids with VLCFA tails may be required for 294 HCMV induced membrane reorganization and for virion infectivity. 295 296 Some lipids were increased by subUL37x1 over WT levels (Fig. 9A) . Several of these lipids 297 were phosphatidylserine (PS) lipids. The mutant virus increased PS species by 4-fold or less 298 ( Fig. 9C) , which was vastly less than the increases observed for PC lipids in WT infected cells 299 ( Fig. 9B ). PS(36:2) was increased by only 1.5-fold. None contained a tail longer than C22 (Fig.  300   9D) . Furthermore, none of these species were increased by WT virus and one-PS(36:2)-was 301 slightly reduced in WT-infected cells compared to uninfected cells (Fig. 9C) . These observations 302
suggest that pUL37x1 suppresses their synthesis. Our lipidomics studies demonstrate that 303 HCMV remodels the host lipidome-increasing the abundance of phospholipids with VLCFA 304 tails-and that the magnitude of the lipidome shift requires pUL37x1. 305 306 HCMV activation of PERK is important for virus induced lipid metabolism (29). Both the level 307 and activation of PERK are induced by HCMV (29, (49) (50) (51) .Given our observation that pUL37x1 308 is important for HCMV lipidome remodeling and the release of Ca 2+ from the ER may induce a 309 stress response (52), we tested if pUL37x1 is required for HCMV-induced PERK protein levels. 310
At 3 dpi, PERK levels were reduced 2-fold in mutant virus infected cells compared to WT-311 infected cells (Fig. 8) . This observation suggests that pUL37x1 control of PERK may be 312 important for HCMV lipid remodeling that we observed. Overall, our data demonstrate that 313 pUL37x1 aids HCMV metabolic remodeling, particularly FA elongation and lipid metabolism. 314
Discussion: 316
Viral metabolic hijacking as a requirement for replication has been demonstrated in many 317 diverse viruses (reviewed in (18, 19, 43, 44, 53-56) ). The virus-host metabolic interaction is 318 important to the infection of α-(13, 15), γ-(57-59), and β-herpesviruses (11, 12, 20) . Like 319 HCMV, Kaposi's sarcoma associated virus (KSHV) increases FA synthesis (60). Recently, the 320 related γ-herpesvirus-murine gammaherpesvirus 68 (MHV68)-replication was suppressed by 321 type I interferon induced limitations on fatty acid and cholesterol metabolism (61). These 322 studies, along with those for HCMV and HSV (described in (18, 43, 44) ) demonstrate that virus-323 metabolic interactions are essential to infection and can be targeted to limit replication. 324
325
HCMV globally remodeling of metabolism requires various host kinases (PERK (29), mTOR (12), 326
CaMKK (22), and AMPK(21, 32)) and transcription factors (SREBPs (12, 28, 33) and chREBP 327 (62)). Our previous observation that HCMV induced FA metabolism requires mTOR activity lead 328 to the finding that pUL38 is required for viral metabolic hijacking (12). We tested the hypothesis 329 that a second viral protein pUL37x1 is required for HCMV metabolic remodeling. The results 330 described here confirm our hypothesis that pUL37x1 also contributes to HCMV remodeling of 331 host metabolism. Similar to pUL38, we found that pUL37x1 contributes to HCMV induced FA 332 elongation and ELOVL7 expression ( Fig. 4-6 ). Using our newly developed LC-MS/MS lipidomic 333 methods, we found that pUL37x1 is needed for HCMV alteration of lipid metabolism (Fig. 9) . 334
During late stages of replication, pUL37x1 causes the accumulation of large vesicles (45). 335
These vesicles may form due to the pUL37x1 dependent FA elongation and lipid synthesis 336 described in this study. In addition to lipidome remodeling by HCMV, we found that pUL37x1 is 337 also necessary for the virus to fully induce PERK expression ( Fig. 8 ). This observation is 338 consistent with the role of PERK in HCMV activation of lipogenesis (29). pUL37x1 may stimulate 339 PERK expression by inducing an ER-stress response triggered when ER stored Ca 2+ is released into the cytosol (52). Although at this time, we cannot rule out other possible 341 mechanisms for pUL37x1 to contribute to the lipidome changes we observed. 342 343 Interestingly, our lipidomic studies further revealed that pUL37x1 suppresses PS lipid levels. PS 344 lipids on the outer leaflet of the plasma membrane is an apoptotic signal (63, 64). Our 345 observations suggest that pUL37x1 is important in limiting the production of lipids associated 346 with apoptosis. Since the PS species that are suppressed by pUL37x1 do not contain saturated 347
VLCFAs produced by ELOVL7 ( Fig. 9) , it is likely that this function of pUL37x1 is independent of 348 its ability to enhance FA elongation. PS synthesis occurs at the mitochondria-associated ER 349 membrane in the same region where pUL37x1 is found (42) (11, 24, 28, 29, 33, 62) . We have previously shown that glucose is metabolized to support fatty 356 acid elongation (12). ELOVL7 is required for HCMV virus release and virion infectivity and 357 synthesizes saturated VLCFAs that become part of the virion lipidome. Here, we report the 358 robust increase of PL-VLCFAs by HCMV. Many of the PL-VLCFAs that were most dramatically 359 increased by HCMV were PC lipids. PC species with shorter tails are the second most abundant 360 PL in the HCMV virus envelope (31). Some of the PC-VLCFAs may be incorporated into the 361 virion. Previously, we demonstrated that the loss of saturated VLCFAs results in a disruption of 362 the infectivity per particle as measured by determining the 'particle-to-infectious-unit ratio' (12). 363
Viruses produced by ELOVL7-depleted cells were 4-8-fold less infectious; i.e. a particle-to-IU 364 ratio that of 400:1 to 800:1 compared to the WT ratio of 100:1 (12). SubUL37x1 viruses also 365 have a disruption in their particle-to-infectious-unit ratio (Fig. 2D ). Our observations that subUL37x1 virus has a disruption in FA elongation and lipid synthesis suggest that the loss of 367 infectivity in the mutant virus is due-at least in part-to disruption in the virus-host metabolism 368 interaction. 369
370
Our work establishes that pUL37x1 is an important player in virus-host metabolic interactions 371 required for HCMV infection. This work demonstrates that HCMV employs multiple 372 mechanisms-pUL37x1 as demonstrated here and pUL38 (12)-to ensure that the host 373 metabolic activity is rewired. Furthermore, our results show that HCMV infection dramatically 374 induces the accumulation of lipids with saturated VLCFAs and highlight the need to continue to 375 study the role of lipid metabolism during HCMV infection. Based on our lipidomic studies, along 376 with our metabolomic analyses (Fig. 3) , we conclude that pUL37x1 is required for HCMV 377 metabolic remodeling but is not necessary to induce viral metabolic hijacking. As such pUL37x1 378 and pUL38 likely coordinate the virus-host metabolism interaction along with other viral factors. 379
Given the reliance of HCMV replication-and viruses in general-on metabolism it is important 380 to define the viral and host mechanisms required for metabolic remodeling. Our results further 381 support the critical functions of pUL37x1 in HCMV replication and provides a foundation for 382 future studies in defining virus-host metabolism interactions to build upon. 
Cells, Virus, and Experimental Setup 389
Human foreskin fibroblast cells (HFF) were cultured in DMEM containing 10% FBS, HEPES, 390 and pen/strep. Prior to infection cells were maintained at full confluence for 3 days in serum-391 containing growth medium. Cells were switched to serum medium-DMEM, HEPES, and 392 pen/strep-the day before infections or mock-infection. Cells were infected with either wild-type 393 (WT) HCMV AD169 strain or subUL37x1, a UL37x1-null virus (36). Both WT and mutant viruses 394 were kindly provided by Dr. Thomas Shenk. All virus stocks were made by pelleting virions from 395 the supernatant of infected cells through a 20% sorbitol. Viruses were resuspended in serum-396 free DMEM medium and stored at -80 °C. Infectious virus titers were measured by the 397 visualizing cytopathic effect and the tissue culture infectious dose (TCID50) method. Since 398 subUL37x1 mutant virus shows minimal CPE, plaque identification was further confirmed by 399 immunofluorescent microscopy. In this case, cells on the TCID50 plate were fixed using 400 methanol and plaques were identified using an anti-pUL123 (IE1) monoclonal antibody (clone 401 1B12) followed by anti-mouse Alexa 488 secondary antibody. This method has similarly been 402 used to quantify a mutant HCMV virus that lacks the UL38 gene (12). Particle-to-IU ratio was 403 done using UL123-specific primers to measure viral DNA (65). 404
405
Metabolic tracer studies were done using 1,6-13 C-glucose and fully labeled 1,2-13 C-acetate 406 sodium salt from Cambridge Isotopes (CLM-2717 and CLM-440, respectively). Following a 1 h 407 infection period, cells were washed with warm PBS three times prior to the addition of serum-408 free DMEM medium containing either 4.5 g/L glucose (25 mM) or 0.0035 g/L acetate (60 µM). 409
For 72 hpi samples, the labeling medium was replenished at 48 hpi. Proteins were examined by Western blot from whole-cell lysates prepared in reducing SDS-413 PAGE sample buffer (25 mM Tris pH 6.8, 5% SDS, 1% 2-mercaptoethanol, glycerol and 414 complete protease inhibitor [Roche]). SDS-PAGE was performed in tris-glycine SDS running 415 buffer using Mini-PROTEAN TGX gels (Bio-Rad). Proteins were transferred to Odyssey 416 nitrocellulose membrane (Li-COR) using a wet-transfer system at 4 ˚C. Western blots were 417 performed using 5% BSA in a Tris-buffered saline with 0.05% tween-20 (TBS-T) for blocking 418 and antibody incubation, except for anti-ELOVL7, anti-ATP citrate lyase and anti-PERK blots 419 which were performed using 3% milk in TBS-T. The following antibodies were used: mouse 420 monoclonal anti-pUL37x1 clone 4B6-B (36), mouse monoclonal anti-pUL36 clone 10C8 (66), 421 mouse monoclonal anti-pUL38 clone 8D6 (67), rabbit polyclonal anti-ELOVL7 (Sigma-Aldrich 422 SAB3500390), rabbit monoclonal anti-AMPKα (Cell Signaling 2603), rabbit polyclonal anti-ATP 423 citrate lyase (Thermo PA5-29497), rabbit polyclonal anti-ACC-1 (Cell Signaling 3662), rabbit 424 polyclonal phospho-ACC-1 Ser79 (Cell Signaling 3661), rabbit monoclonal anti-PERK (Cell 425
Signaling 3192), rabbit monoclonal anti-ACCS2 (Cell Signaling 3658), mouse monoclonal anti-426 actin (LI-COR 929-42212), and mouse monoclonal anti-α-tubulin (Sigma-Aldrich T6199). Blots 427 using mouse monoclonal anti-HCMV, anti-actin and anti-tubulin antibodies were incubated for 1 428 h at room temperature. All others were done overnight at 4 ˚C. Quantification of Western blots 429 was done using a LI-COR Odyssey CLx imaging system. 430
431
Metabolomics and Metabolite Analysis 432
All metabolite measurements were done using liquid-chromatography high resolution tandem 433 mass spectrometry (LC-MS/MS). At various times after infection, metabolic reactions were 434 rapidly quenched using cold 80% methanol and extracted as previously described (14, 23) . 435
Extracted water-soluble metabolites were dried under nitrogen gas and resuspended in Optima 436 HPLC-grade water (Fisher Chemical) for reverse phase liquid chromatography or 50% methanol 437 for hydrophilic interaction chromatography (HILIC). Mass spectrometric analysis was performed by four Thermo Scientific mass spectrometers: Quantum Ultra triple-quad, Quantum MAX triple-439 quad, Exactive orbitrap and Q-Exactive Plus orbitrap. Metabolites were measured in both 440 positive and negative modes using reverse phase or HILIC separation (68, 69). Metabolites 441 were identified using mass spectral and UHPLC retention time data that were generated from 442 external standards. Peaks were examined, and metabolites identified using Compound 443
Discovery software (Thermo) and Metabolomic Analysis and Visualization Engine (MAVEN) (68, 444 70). Each metabolite was measured using two technical replicates per experiment. Each 445 metabolic experiment contained controls for determining ionization artifacts and sample 446 degradation. All chemical and solutions for metabolomics, fatty acid analysis, and lipidomics. 447
were HPCL or MS-grade. 448 449 Fatty Acid Analysis. 450
Fatty acid (FA) analyses were performed as previously described (12, 17) . Briefly, lipids were 451 extracted from cells lysed using cold 50% methanol containing 0.05 M HCl. Cells were scraped 452 and transferred to glass vials. Lipids were chloroform extracted and FA tails were chemical 453 cleaved via saponification at 80 ˚C for 1h in a basic methanol buffer. The FAs were isolated 454 using hexane and dried down under nitrogen gas. Following a resuspension in 1:1:0.3 455 methanol:chloroform:water or 1:1:1 methanol:chloroform:isopropanol FAs were analyzed by 456 UHPLC and high-resolution mass spectrometry. FAs were examined using a Luna C8 reversed-457 phase column (Phenomemex) and Exactive orbitrap mass spectrometer (12) or a Q-Exactive 458
Plus mass spectrometer. In the latter case, FAs were separated using the same column but 459 utilized the same LC buffer solutions as used for lipid analysis described below. FA spectrums 460 were collected using 140,000 resolution (at 200 m/z). Experiments utilizing metabolic tracers 461 and FA labeling were additionally analyzed at 280,000 resolution. The data was analyzed and 462 FA levels quantified using MAVEN. For labeling experiments, the data were corrected for naturally occurring carbon-13 using MATLAB (12). Each sample was measured using two 464 technical replicates per experiment. 465 466 Lipidomics and Lipid Analysis. 467
Similar to the FA analysis, lipids for lipidomics were extracted by 50% methanol and chloroform. 468
The chloroform was removed by drying the samples under nitrogen gas. Lipids were 469 resuspended in 1:1:1 methanol:chloroform:isopropanol. If needed, samples were stored under 470 nitrogen gas at -80 ˚C. Samples were normalized according to cell number: 125 µl of 1:1:1 471 resuspension solution per 100,000 cells. After resuspension, lipids were kept at 4 ˚C. Lipids 472 were separated via UHPLC using a Kinetex 2.6 µm C18 column (Phenomenex 00F-4462-AN) at 473 60 ˚C on a Vanquish system. Two solvents were used for UHPLC: solvent A (40:60 474 water:methanol plus 10 mM ammonium formate and 0.1% formic acid) and solvent B (10:90 475 methanol:isopropanol plus 10 mM ammonium formate and 0.1% formic acid). UHPLC was 476 performed at 0.25 ml/min flow rate using the following gradient conditions: 75% solvent A / 25% 477 solvent B for 2 min; 35% A / 65% B for 2 min at curve value = 4; held at 35% A / 65% B for 1 478 min; 0% A / 100% B for 11 min at curve value = 4; and held at 0% A / 100% B for 4 mins. The 479 column was briefly washed and re-equilibrated before the next run. In total each run lasted 30 480 min. All lipids were examined using a Q-Exactive Plus mass spectrometer operating in a data-481 dependent Full MS/dd-MS2 TopN mode. MS1 data was collected at either 70,000 or 140,000 482 resolution at 200 m/z using AGC = 1e6 with transient times of 250 ms and 520 ms, respectively. 483
Spectrum were collected over a 200-1600 m/z mass range. MS2 spectrum were collected using 484 35,000 resoluton, AGC = 1e5 and 120 ms maximum injection time. Each sample was run twice, 485 using 10 µl for negative mode and 8 µl of sample for positive mode. In negative mode, a 486 normalized collision energy (NCE) value of 20 was used. In positive mode, the NCE value was 487 increased to 30. All lipids were ionized using a heated electrospray ionization (ESI) source. The 488
following ESI parameters were used in negative mode: sheath gas flow rate = 44; auxiliary gas 489 flow rate = 14; sweep gas flow rate = 2; spray voltage = 3.3 kV; S-lens RF =76; aux gas temp 490 220 ˚C; and capillary temp = 320 ˚C. Similar settings were used in positive mode except the 491 spray voltage was increased to 3.5 kV and S-lens RF level was decreased to 65. The 492 instrument was calibrated weekly. For labeling experiments, the instrument was calibrated 493 immediately before the start of analysis. As with metabolites and FA, lipids were measured 494 using two technical replicates per experiment. Lipidomic data was analyzed using MAVEN and 495
LipidSearch (Thermo Scientific). 496
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Rabinowitz for providing advice and assistance with the early stages of these studies. We are 501 grateful to Felicia Goodrum, Jim Alwine, Lynn Enquist, the members of the Goodrum lab and 502 the other members of the Purdy lab for helpful discussion regarding this work. Western blot analysis reveals that subUL37x1 fails to express pUL37x1 while the expression of 526 neighboring genes is unaffected. (B) Infection in fully confluent fibroblast cells in serum-free 527 conditions was visually tracked from 6 hpi to 4 dpi. Images from uninfected control cells at 6 hpi 528 and 4 dpi is also included. (C) Infectious virus particles released by cells infected with WT or 529 mutant subUL37x1 was measured at 4 dpi at MOI = 3. (D) The particle-to-infectious units as 530 measured by viral DNA and TCID50 were compared for particles released by WT or subUL37x1 531 infected cells at 4 dpi, MOI = 3. For (C) and (D) the error bars are the standard deviation from 532 three independent experiments (N = 3). * p = 0.05 -0.01; ** p = <0.01; t-test. 
